Maes, M., Al-Rubaye, H., Almulla, A., Stoyanova, K., al., e. Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways,
, .
Maes, M., Al-Rubaye, H., Almulla, A., Stoyanova, K., al., e. .
Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways.
: , .
Maes, M., Al-Rubaye, H., Almulla, A., Stoyanova, K., al., e. ()
Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways,
:
Maes, M.,
Al-Rubaye, H.,
Almulla, A.,
Stoyanova, K., &
al., e.
().
Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways. International Journal of Environmental Research and Public Health; International Journal of Environmental Research and Public Health.